About AiCure
AiCure is a company based in New York (United States) founded in 2010 by Gordon Kessler. AiCure has raised $55.75 million across 11 funding rounds from investors including SVB, New Leaf Venture Partners and HHS. The company has 16 employees as of December 31, 2022. AiCure offers products and services including H.Code, eCOA - ePRO, and Adherence and Dosing. AiCure operates in a competitive market with competitors including Wellth, Cureatr, Phil, Capsa Healthcare and Spencer Health Solutions, among others.
- Headquarter New York, United States
- Employees 16 as on 31 Dec, 2022
- Founders Gordon Kessler
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$55.75 M (USD)
in 11 rounds
-
Latest Funding Round
$12 M (USD), Debt – Conventional
Jan 23, 2024
-
Investors
SVB
& 13 more
-
Employee Count
16
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AiCure
AiCure offers a comprehensive portfolio of products and services, including H.Code, eCOA - ePRO, and Adherence and Dosing.
AI tool for monitoring and assisting clinical trial participants.
Captures participant responses to support trial data collection.
Tracks participant adherence to prevent trial dropouts.
People of AiCure
Unlock access to complete
Funding Insights of AiCure
AiCure has successfully raised a total of $55.75M across 11 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $12 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in AiCure
AiCure has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, New Leaf Venture Partners and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Tech & Life-Sciences focused Stage-agnostic VC firm investing in geographies such as North America
|
Locked | Locked | Locked | |
|
Venture capital investments are backed by Singtel through Innov8.
|
Locked | Locked | Locked |
Investor details for AiCure
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AiCure
Investment portfolio details for AiCure
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - AiCure
Detailed financials for AiCure
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aicure Comparisons
Peer comparison for AiCure
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AiCure
AiCure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wellth, Cureatr, Phil, Capsa Healthcare and Spencer Health Solutions, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provides AI and cloud-based platform for doctors for patient engagement and care
|
|
| Locked | Locked | Locked |
Cloud-based medication management software is provided for healthcare providers.
|
|
| Locked | Locked | Locked |
Prescription drugs refill management solutions
|
|
| Locked | Locked | Locked |
Medication management systems are supplied to healthcare providers and pharmacies.
|
|
| Locked | Locked | Locked |
Devices and apps for medication adherence are provided.
|
|
| Locked | Locked | Locked |
Cloud-based medication adherence monitoring is provided for healthcare providers.
|
Detailed competitors of AiCure
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aicure
Complete news archive for AiCure
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AiCure
AiCure was founded in 2010 and raised its 1st funding round 1 year after it was founded.
AiCure is headquartered in New York, United States. It is registered at New York, New York, United States.
Edward Ikeguchi is the current CEO of AiCure.
AiCure is a funded company, having raised a total of $55.75M across 11 funding rounds to date.
As of Dec 31, 2022, the latest employee count at AiCure is 16.
AiCure was established in 2010 in New York, United States, as a SaaS provider in the health technology sector. An AI-based platform is utilized to monitor medication adherence through visual verification in clinical trials and routine care settings. Machine learning, computer vision, and big data are applied via mobile devices, with patented facial recognition and motion-sensing features employed to observe patient actions during medication intake.
AiCure's top competitors include Wellth, Phil and Capsa Healthcare.
AiCure offers H.Code, eCOA - ePRO, and Adherence and Dosing.
AiCure has 14 investors. Key investors include SVB, New Leaf Venture Partners, HHS, Singtel Innov8, and Palisades Growth Capital.